市場調査レポート
商品コード
1397174
カプノグラフィ装置の世界市場:洞察、競合情勢、市場予測:2028年Capnography Devices - Market Insights, Competitive Landscape and Market Forecast-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
カプノグラフィ装置の世界市場:洞察、競合情勢、市場予測:2028年 |
出版日: 2023年12月18日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 1~3営業日
|
世界のカプノグラフィ装置の市場規模は、2022年に5億8,700万米ドルと評価され、2023年から2028年の予測期間中に7.27%のCAGRで拡大すると予測されています。カプノグラフィ装置の需要は、主に呼吸器感染症、慢性閉塞性肺疾患(COPD)、喘息、肺がんなどの呼吸器疾患の有病率の上昇によって押し上げられています。さらに、世界中で外科手術が増加していることも、2023年~2028年の予測期間中にカプノグラフィ装置市場の成長に寄与している要因の1つです。
2019年の慢性閉塞性肺疾患(COPD)の有病率は10.3%で、世界全体で約3億9,190万症例に上ると推定されています。さらに、2023年の世界保健機関(WHO)は、慢性閉塞性肺疾患は、2019年に世界中で323万人の死亡につながり、死因の第3位になったと述べています。さらに、世界保健機関(WHO)2022が提供したデータによると、2020年には世界全体で約221万人の肺がんの新規症例があったと推定されています。このように、大気汚染の増加、タバコの喫煙、職業上のリスクなどの様々な要因に起因する呼吸器疾患の有病率の上昇は、呼吸器疾患の検出と管理の必要性を生み出し、その結果、カプノグラフィ装置市場の促進要因となるとみられています。
カプノグラフィ装置市場のもう1つの主要促進要因は、パルスオキシメータと比較してカプノグラフィ装置が提供するさまざまな利点です。一方、血液中の酸素飽和度を測定するパルスオキシメータは、特定の呼吸器疾患を検出できない可能性があります。さらに、カプノグラフィ装置は患者の呼吸パターンを評価するのに役立ち、気道閉塞を検出することができます。このように、カプノグラフィ装置によって提供されるさまざまな利点と用途は、最終的にカプノグラフィ装置市場の成長を後押しします。
しかし、カプノグラフィ装置に関連する高コストと市場で安価な代替品が利用可能であることは、カプノグラフィ装置市場の成長を制限する可能性のある主要な抑制要因の一部です。
当レポートでは、世界のカプノグラフィ装置市場について調査し、市場の概要とともに、技術別、用途別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。
Capnography Device Market By Technology (Side Stream, Main Stream, And Micro Stream), Application (Respiratory Monitoring, Cardiac Care, Trauma And Emergency Care, And Other Applications), End-User (Hospitals, Ambulatory Surgical Centers, And Other End-Users) and geography is expected to grow at a steady CAGR forecast till 2028 owing to the rising prevalence of respiratory disorders and increasing number of surgical procedures across the globe.
The global Capnography Device Market was valued at USD 587 million in 2022, growing at a CAGR of 7.27% during the forecast period from 2023 to 2028. The demand for capnography devices is primarily being boosted by the rising prevalence of respiratory disorders such as respiratory infections, chronic obstructive pulmonary disease (COPD), asthma, and lung cancer. Additionally, the increasing number of surgical procedures across the globe is another factor that is contributing to the growth of the Capnography market during the forecast period from 2023-2028.
As per the study "Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modeling analysis" published in "The Lancet Respiratory Medicine" in 2022 estimated that the prevalence of chronic obstructive pulmonary disease (COPD) was 10.3% in the year 2019, which accounted for around 391.9 million cases, globally. Additionally, the World Health Organization (WHO) 2023, stated that chronic obstructive pulmonary disease became the third leading cause of death as it led to 3.23 million deaths in the year 2019, across the globe. Further, as per the data provided by the World Health Organization 2022, it was estimated that there were around 2.21 million new cases of lung cancer in 2020, globally. Thus, the rising prevalence of respiratory disorders owing to various factors including increasing air pollution, tobacco smoking, and occupational risks, will create a need for the detection and management of respiratory disorders, thus resulting in the positive growth of the Capnography Device market.
Another key driver for the Capnography Device market is the various advantages provided by the Capnography devices over pulse oximeters. The capnography devices provide continuous monitoring of carbon dioxide in the exhaled breath, allowing early detection of respiratory disorders, on the other hand, a pulse oximeter which measures oxygen saturation in the blood, might not be able to detect certain respiratory disorders. Additionally, capnography devices help to assess patients breathing patterns and are capable of detecting airway obstruction. Thus, the various advantages and applications provided by the capnography devices will eventually boost the growth of the Capnography Device market.
However, the high cost associated with the capnography devices and the availability of inexpensive alternatives in the market, are some of the key constraints that may limit the growth of the Capnography Device market.
Capnography Device Market by Technology (Side Stream, Main Stream, and Micro Stream), Application (Respiratory Monitoring, Cardiac Care, Trauma and Emergency Care, and Other Applications), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the technology segment of the Capnography Device market, the mainstream category is estimated to amass a significant revenue share in the Capnography Device Market in 2022. This can be attributed to the various advantages provided by Main Steam capnography devices. Mainstream capnography devices provide real-time feedback on the changes in CO2 levels during the respiratory cycle. Additionally, the device offer accurate readings even in dynamic conditions such as varying respiratory rates and tidal volumes, thus providing a reliable assessment of the patient's respiratory status. Therefore, other various advantages provided by the mainstream category such as ease of use, accuracy, and shorter response time are some of the other key factors contributing to the growth of the segment.
Furthermore, as the demand for this segment grows, various novel products are getting regulatory approval from various regulatory organizations across the world. For example, in April 2021, the US FDA provided FDA 510(k) clearance to Radius PCGTM, a portable real-time capnograph with wireless Bluetooth® connectivity.
Therefore, owing to the above-mentioned factors, the mainstream category is expected to register significant growth, thereby driving the growth of the overall Capnography Device market during the forecast period.
North America is expected to account for the highest proportion of the Capnography Device Market in 2022, out of all regions. This is due to the presence of developed and sophisticated healthcare infrastructure, and the high prevalence of respiratory disorders such as respiratory infections, chronic obstructive pulmonary disease (COPD), asthma, and lung cancer in the region. Additionally, rising technological advancements, presence of major players in the region, and a highly viable market in terms of product development, and launches are some of the factors driving the growth of the Capnography Device Market in North America.
According to the data provided by the American Society of Cancer 2023, it was estimated that there were around 2,38,340 new cases of lung cancer in the United States in 2023. Additionally, according to the data provided by the Centers for Disease Control and Prevention 2021, it was estimated that around 25 million people in the United States were suffering from asthma in the year 2021. Thus, the rising prevalence of various respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Lung Cancer will create a need for the detection and management of respiratory disorders, thus resulting in the positive growth of the Capnography Device Market in the United States, which will eventually propel the Capnography Device market in North America.
Additionally, the presence of key market players in the region including GE Healthcare, Masimo, Nonin, and Stryker is another contributing factor responsible for the growth of the Capnography Device market in North America.
Further, various key product launches and product approvals in the region are other factors that are influencing the positive growth of the market in North America. For Example, in Septembe 2020, Capsule Technologies received FDA 510(k) clearance approval from the USFDA for its capnography monitoring solution Vitals Plus with the Masimo NomoLine ISA CO2 Module.
Therefore, the factors mentioned above, and the presence of key market players with increasing product launches and product approvals in the region are some of the important factors which are responsible for driving the overall market for Capnography Devices in North America during the forecast period.
Some of the key market players operating in the Capnography Device market include: Koninklijke Philips N.V., Masimo, Medtronic, Nihon Kohden Corporation, Dragerwerk AG & Co. KGaA, Infinium Medical, Nonin, TreyMed, Inc., Contec, BD, MEDACX Ltd., Stryker, Hamilton Medical, ICU Medical, Baxter, EDAN Instruments, Inc., GE Healthcare, Zoll Medical Corporation, Avante Health Solutions, and Criticare Technologies, Inc.